cases, the syndromes of depression and cognitive impairment may be related to the same underlying disorder (eg, vascular dementia, hypothyroidism), whereas in other cases, they may be relatively independent and simply coexist. Cognitive deficits in late-life depression span multiple domains; however, deficits in executive functions may be particularly important as their presence predicts poor clinical outcomes. Cognitive impairment, when mild, does not appear to progress to dementia in most cases, but variability in the course of elders with depression and cognitive impairment suggests the need for careful follow-up, particularly in cases where executive dysfunction is suspected. The Expert Consensus Guideline recommends antidepressant drug therapy combined with a psychosocial intervention as the treatment of choice for geriatric depression. New treatments including computerized cognitive remediation and problem-solving therapy may be particularly effective in treating both affective and cognitive symptoms. A lthough estimates vary, studies have shown that combined depression and cognitive dysfunction is present in roughly 25% of older adults. 1 The number of community residents with both depressive symptoms and impaired cognition doubles every 5 years after the age of 70. In some cases, the syndromes of depression and cognitive impairment may be related to the same underlying disorder (eg, vascular dementia, hypothyroidism), whereas in other cases, depression and cognitive impairment may be relatively independent and simply coexist. Differential diagnosis and treatment decisions can be complicated by various factors. Cognitive changes, which are part of the depressive syndrome, can be severe; incipient dementing disorders may have C M E behavioral and physical symptoms that mimic depression; or cognitive impairment may be part of a subclinical dementing disorder unmasked by the pathophysiological changes of depression.
CoGniTive iMPAiRMenTS in GeRiATRiC DePReSSeD PATienTS wiTHouT DeMenTiA
Neuropsychological impairments spanning many cognitive domains, including episodic memory, visuospatial skills, verbal fluency, and psychomotor speed, have been reported consistently in late-life depression. These impairments, particularly memory impairment, were attributed to dysfunction in subcortical structures related to mood regulation, such as the hippocampus. 2 Deficits in executive function are also common in geriatric depression, occurring in nearly 40% of elderly depressed patients. 3 Replicated studies have indicated that among cognitive impairments, deficits in executive functions are of particular importance given their negative effect on clinical outcomes. [4] [5] [6] [7] [8] This topic is further discussed below.
DePReSSion in PATienTS wiTH DeMenTinG DiSoRDeRS
Estimates of the rates of depression in dementing disorders range from 20% to 50%. 9 Major depression or clinically significant depressive symptoms can be found in 17% to 40% of Alzheimer's disease (AD) patients. 10 Depression in AD is notable for prominent disturbances in initiation or motivation, fatigue, psychomotor slowing, and apathy. Patients with subcortical dementias, including vascular dementia and Parkinson's disease (PD), are more likely to experience depression than patients with AD, with rates in PD reaching 50%. 11 Symptoms of depression often overlap with the physical and motor symptoms of PD, which may make differential diagnosis particularly challenging.
An episode of depression first occurring in late life is, in some cases, a prodrome of a dementing disorder. Depressed mood has been associated with an increased risk of incident dementia. 12 For example, depressive symptoms predicted cognitive decline of elderly women during a 4-year follow-up study. 13 In patients with subthreshold cognitive symptoms, those suffering concurrent depressive symptoms are more likely to progress to dementia. 14 Usually there is a significant decline in functioning that precedes late-onset depressive symptoms in AD, and cognition declines subsequently. 10 The prevalence of depressive symptoms decreases as AD progresses. Patients exhibit fewer mood-related symptoms but experience increased agitation and psychomotor slowing. The rates of depression in AD patients remain stable for roughly the first 3 years of follow-up. Rates of depression decline in the fifth year of follow-up by as much as 30%.
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DePReSSion AS A RiSK FACToR FoR DeMenTiA
Studies attempting to link geriatric depression with subsequent dementia have shown conflicting results. A recent metaanalysis showed an almost two-fold risk for the development of AD in patients with history of depression. 15 A study of Chinese and U.K. subjects showed that only the most severe depressive syndromes increase the risk for later development of dementia.
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DePReSSion wiTH ReveRSible DeMenTiA SynDRoMe
Some older adults with late-life depression may exhibit a reversible dementia syndrome (previously termed "pseudodementia"), ie, a cognitive impairment that mimics dementia but subsides upon remission of depression. These patients usually have a severe, late-onset depression but a mild dementia syndrome. When compared to AD patients with concomitant depression, patients with reversible dementia have more psychic and somatic anxiety, early-morning awakening, and loss of libido. 17 It is important to note that a large percentage of these patients progresses into irreversible dementia within 2 to 3 years.
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CoGniTive iMPAiRMenT AnD THe CouRSe oF DePReSSive SyMPToMS/ SiGnS Abnormal performance on select tests ( Table 1 ) of executive functioning predicts adverse clinical outcomes in geriatric depression, including poor and slow antidepressant response, relapse, and higher levels of functional disability. The term "executive functions" encompasses a variety of cognitive abilities, such as planning, organizing, self-monitoring, inhibiting prepotent responses, and strategy generation. 19 Furthermore, performance on measures of executive function can affect and be affected by performance in non-executive cognitive domains, such as processing speed and memory. 20 For example, decrements in performance on the initiation/perseveration (I/P) subscale of the Dementia Rating Scale (DRS) and the Stroop Color Word tests predicted poor response to selective serotonin reuptake inhibitors (SSRIs). 7, 8 Though not a classic measure of executive function, the I/P subscale of the DRS tests multiple coordinated cognitive skills that require executive functioning.
To clarify the specific executive functions associated with remission, we completed an analysis that examined the contribution of each function individually. Among the functions tested by the I/P, only semantic fluency (the complex verbal portion, or CV/IP) predicted remission during treatment with escitalopram. 6 Performance on speeded verbal tasks such as the CV/IP can be improved by the use of strategies, such as the organization of responses into superordinate verbal categories (eg, replying with words belonging to the same category. For example, fruit: grapes, bananas, oranges, etc.), rather than separate categories (eg, bread, bananas, milk, etc.) Completing strategic semantic tasks such as the CV/IP also requires selection of words from multiple activated responses, and C M E suppression of semantically or phonemically related but inapplicable words. In the above study, the use of semantic strategy, an executive function, explained performance differences between remitters and non-remitters. 6 We followed up these findings with a second study that demonstrated that the use of the same executive function, semantic strategy explained both verbal memory performance and remission rates of geriatric depression. 5 These studies are the first to define a single executive function that predicts low remission rates during antidepressant drug treatment, regardless of the task by which it is elicited. Testing semantic strategy could be a useful tool added to the clinical assessment of depressive symptoms to improve the clinicians' ability to identify patients at risk for poor antidepressant drug response.
5
PRoGnoSiS oF CoGniTive iMPAiRMenT
The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) includes "mild neurocognitive disorder," a disorder with modest decline from previous performance in one or more cognitive domains (ie, complex attention, executive function, learning and memory, language, perceptual motor, or social cognition). In non-depressed older adults, mild neurocognitive disorder is a heterogeneous entity and includes a large subgroup that develops major neurocognitive disorders on followup. It remains unclear whether mild cognitive impairment during late-life depressive episodes is a predictor of late development of dementia since mild cognitive impairment is part of late-life depression itself. In fact, mild executive dysfunction during depressive episodes in late life is a stable disturbance that improves modestly when depressive symptoms are ameliorated. 7 Nonetheless, follow-up studies have suggested that geriatric patients with depression and more severe cognitive symptoms, such as reversible dementia, are at an increased risk for developing irreversible dementia. 18 Taken together, these studies suggest that 9% to 25% of elderly patients with depression and an initially reversible dementia develop irreversible dementia each year. In addition, some patients who present with both cognitive dysfunction and late-onset depression may already be experiencing the beginning stages of a dementia. This view is supported by recent studies that suggested depression may be a prodrome of some dementing disorders. 21 
evAluATion
Assessment of depressive syndromes in cognitively impaired patients is complicated by the symptom overlap with dementia, the instability of depressive symptoms over time, and the poor ability of elderly patients to report their symptoms. If criteria for one of the depressive syndromes are met, an antidepressant treatment trial should be offered. Beyond the benefits of alleviating the suffering and complications of depression, remission of the depressive syndrome can increase the clinician's ability to evaluate the severity of the remaining cognitive impairment and plan for further treatment and follow-up. If significant cognitive impairment is identified, the clinician should consider referral for neuropsychological evaluation that can quantify impairment in specific domains and aid diagnosis. Variability in the course of elders with depression and cognitive impairment suggests the need for careful follow-up, particularly in cases where executive dysfunction is suspected.
PHARMAColoGiC TReATMenT
The Expert Consensus Guideline recommends antidepressant drug therapy combined with a psychosocial intervention as the treatment of choice for geriatric depression. 22 Tricyclic antidepressants may not improve and may even worsen the cognitive functions of depressed older adults. Nortriptyline was shown to compromise verbal learning performance of depressed older adults more than placebo. 24 Conversely, some SSRIs may improve cognitive function, mainly in patients whose depressive symptoms subside after treatment. Specifically, sertraline has been shown to improve performance on tests of attention, episodic memory, and executive function, but only in treatment responders. 24 Similarly, depressed older patients with an antidepressant response to citalopram showed improvement in psychomotor speed and visuospatial functioning. However, citalopram treatment appeared to worsen verbal learning and processing speed in patients who remained depressed despite treatment. 25 Further discussion on pharmacotherapy of late-life depression can be found in the article by Avari et al., also in this issue.
PSyCHoTHeRAPieS
Non-pharmacological interventions should be considered, particularly in patients who do not respond fully to pharmacotherapy. Psychotherapies have been developed to remedy the behavioral deficits of depressed older adults with cognitive impairments associated with poor response to antidepressants. As an example, problem-solving therapy (PST) was modified to directly treat behavioral abnormalities of patients with late-life depression and executive dysfunction. PST is based on the premise that helping patients become better managers of their lives reduces stress and thus ameliorates depression. PST trains patients to identify problems central to their well-being and provides a method for selecting and implementing problem-solving plans. PST aimed at remedying behavioral deficits has been effective in treating elderly depressed patients with executive dysfunction. 26 The article by McGovern et al. in this volume offers a detailed discussion on psychotherapies for depressed older adults with and without cognitive impairment.
CoMPuTeRizeD CoGniTive ReMeDiATion
Certain types of computerized cognitive remediation can improve brain functioning C M E C M E by inducing neuroplasticity (ie, neuroplasiticity-based computerized cognitive remediation, or nCCR). We have proposed that computerized cognitive remediation that relies on the induction of neuroplasticity and targets brain networks associated with clinical outcomes in late-life depression has the potential to improve treatment response. Recently, we developed a novel treatment model using nCCR to improve the functioning of cerebral networks responsible for executive functioning and associated with poor response to antidepressants. 27 Our nCCR treatment model is based on the assumption that neuroplastic changes that improve the function of cerebral network abnormalities contributing to antidepressant resistance would improve symptoms and signs of late-life depression. Preliminary evidence suggests that nCCR treatment induces a clinically meaningful improvement of both cognitive and affective symptoms. 28 
Tests for Cognitive impairment in older Adults
ConCluSionS
Impairment in episodic memory, visuospatial skills, verbal fluency, and psychomotor speed are common in late-life depression. Despite these cognitive abnormalities, most depressed older adults do not develop dementia syndromes. However, some cases of late-onset depression represent the first behavioral abnormalities (prodrome) of dementing disorders. A large number of older adults suffering from depression with reversible dementia proceed to develop Alzheimer's disease or mixed Alzheimer's and vascular dementia. This syndrome was previously termed "pseudo-dementia" because it was incorrectly thought to have a benign long-term outcome. Finally, early-onset, recurrent, severe depression is a risk factor for development of dementia in late life.
Replicated findings suggest that executive dysfunction predicts poor or slow response to antidepressant drugs. Psychotherapies have been developed to address the behavioral deficits of depression with executive dysfunction and found effective.
Neuroplasticity-based computerized cognitive remediation targeting brain networks responsible for executive functioning has been developed, and preliminary studies are encouraging.
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